Millennium Management LLC lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 287.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 146,877 shares of the company's stock after purchasing an additional 108,988 shares during the period. Millennium Management LLC owned about 0.11% of Henry Schein worth $9,415,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in the stock. Summit Securities Group LLC purchased a new stake in shares of Henry Schein in the 2nd quarter worth $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the 2nd quarter worth about $37,000. Blue Trust Inc. increased its position in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after purchasing an additional 475 shares during the period. Mather Group LLC. increased its position in Henry Schein by 16.8% during the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company's stock valued at $96,000 after purchasing an additional 216 shares during the period. Finally, Palisade Asset Management LLC bought a new stake in shares of Henry Schein in the 1st quarter valued at about $113,000. Hedge funds and other institutional investors own 96.62% of the company's stock.
Henry Schein Stock Performance
Shares of NASDAQ HSIC traded up $0.52 during midday trading on Wednesday, reaching $70.51. The company had a trading volume of 666,744 shares, compared to its average volume of 1,340,169. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The business's 50-day simple moving average is $70.03 and its 200 day simple moving average is $70.02. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.03 billion, a P/E ratio of 23.82, a P/E/G ratio of 2.01 and a beta of 0.86.
Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to analysts' expectations of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm's revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.31 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
HSIC has been the topic of several research reports. Barrington Research reissued an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. Baird R W upgraded Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. Robert W. Baird dropped their price objective on Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 7th. Piper Sandler reiterated an "overweight" rating and issued a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Finally, Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Henry Schein has a consensus rating of "Hold" and a consensus target price of $77.50.
Get Our Latest Research Report on HSIC
Insider Buying and Selling at Henry Schein
In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 1.14% of the company's stock.
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.